2024年年度权益分派实施公告 证券代码：600821 证券简称：金开新能 公告编号：2025-047 金开新能源股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.1元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/7/7 | － | 2025/7/8 | 2025/7/8 | 差异化分红送转： 是 一、通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 6 月 4 日的2024年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》，公司通过回购专用 证券账户所持有的 ...

Core Viewpoint - The company is making a capital injection of up to 124,722.56 million RMB into its wholly-owned subsidiary, Jinkai Energy (Beijing) Energy Saving Technology Co., Ltd., to support its operational development and enhance its competitiveness [2][3][5]. Group 1: Investment Overview - The investment amount is capped at 124,722.56 million RMB, which will be used by the wholly-owned subsidiary, Jinkai Limited, to inject capital into Jinkai Energy [2][3]. - The capital injection has been approved by the company's general manager's office and does not require further approval from the board of directors or shareholders [3]. Group 2: Basic Information of the Investment Target - Jinkai Energy was established on May 16, 2025, and is located in Beijing [4]. - The company is a limited liability company with a registered capital of 1 million RMB and operates in areas such as energy management and renewable energy technology services [4]. Group 3: Impact of the Investment - The capital injection aims to enhance the subsidiary's operational capabilities and provide necessary support for project advancement, aligning with the company's strategic planning [5][6]. - The company's financial status is stable, and the use of self-owned funds for this investment will not adversely affect its normal operations or cash flow [6].

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

证券代码：600821 证券简称：金开新能 公告编号：2025-046 金开新能源股份有限公司 关于向全资子公司注资的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资标的名称：金开新能(北京)节能技术有限公司（以下简称"金开节 能"），为金开新能科技有限公司（以下简称"金开有限"）全资子公司。 投资金额：金开有限为金开新能源股份有限公司（以下简称"金开新能" 或"公司"）全资子公司，向金开节能注资不超过 124,722.56 万元人民币。 相关风险提示：本次注资不涉及关联交易，亦不构成上市公司重大资产 重组，不会改变公司合并报表范围。 一、投资情况概述 公司全资子公司金开有限使用自有资金对其全资子公司金开节能注资不超 过 124,722.56 万元人民币。根据《公司章程》《上海证券交易所股票上市规则》 等规定，本次注资已经公司总经理办公会会议审议通过，无需提交公司董事会和 股东会审议。本事项不构成关联交易，也不构成《上市公司重大资产重组管理办 法》规定的重大资产重组。 二、投资标的基本情况 ...

Core Viewpoint - The company, Jinkai New Energy Co., Ltd., announced that its controlling shareholder, Tianjin Jinkai Enterprise Management Co., Ltd., has completed a share buyback plan, acquiring a total of 62,823,519 shares, which represents 3.15% of the company's total share capital, with a total investment of approximately RMB 357 million [1][3][4]. Summary by Sections Share Buyback Plan - The controlling shareholder plans to increase its stake in the company through a buyback plan, with a total investment amount ranging from RMB 200 million to RMB 400 million [1]. - The buyback plan was first disclosed on November 12, 2024, and the implementation period was set from November 22, 2024, to June 11, 2025 [2][3]. Implementation Results - As of June 11, 2025, the controlling shareholder has successfully acquired 62,823,519 shares, amounting to a total investment of RMB 357 million [3][4]. - The buyback plan has been completed without triggering a mandatory tender offer and has not affected the company's listing status or the control of the company [4]. Compliance and Regulations - The buyback actions comply with relevant laws and regulations, including the Company Law of the People's Republic of China and the Securities Law of the People's Republic of China [4]. - The company has fulfilled its information disclosure obligations as required by the Shanghai Stock Exchange and other regulatory bodies [4].

金开新能源股份有限公司 证券代码：600821 证券简称：金开新能 公告编号：2025-045 关于控股股东增持公司股份计划实施完毕暨增持结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、增持主体的基本情况 | 增持主体名称 | 天津金开企业管理有限公司 | | | | --- | --- | --- | --- | | 增持主体身份 | 控股股东或实控人 | 是 | 否 | | | 控股股东或实控人的一致行动人 | 是 | 否 | | | 直接持股 5%以上股东 | 是 | 否 | | | 董事、监事和高级管理人员 其他：__________ | 是 | 否 | | 增持前持股数量 | 189,078,638 股 | | | 已披露增持计划情况：金开新能源股份有限公司（以下简称"公司"） 控股股东天津金开企业管理有限公司（以下简称"金开企管"）计划自 2024 年 11 月 12 日起 12 个月内，以自有资金和自筹资金(包括股票增 持专项贷款)通过上海证券交易所系统采 ...

Market Performance - As of June 6, the Tianjin Free Trade Zone concept index rose by 2.60%, ranking second among concept sectors, with seven stocks increasing in value [1] - Notable gainers included HNA Technology, Bohai Chemical, and Haitai Development, which hit the daily limit, while HNA Technology, Tianjin Pulin, and Youfa Group saw increases of 9.03%, 2.68%, and 1.56% respectively [1] Sector Comparison - The Tianjin Free Trade Zone concept was among the top-performing sectors, with a net inflow of 120 million yuan from main funds, indicating strong investor interest [2] - The leading stocks in terms of net fund inflow were HNA Technology, Bohai Chemical, and Jintou City Development, with net inflows of 90.06 million yuan, 86.73 million yuan, and 47.65 million yuan respectively [2] Fund Flow Analysis - The net inflow ratios for Haitai Development, Jintou City Development, and Bohai Chemical were 51.10%, 20.62%, and 14.08% respectively, indicating significant investor confidence in these stocks [3] - The detailed fund flow data showed that HNA Technology had a trading volume of 90.06 million yuan with a turnover rate of 9.89%, while Bohai Chemical had a turnover rate of 13.09% [3][4]

证券代码：600821 证券简称：金开新能 公告编号：2025-044 金开新能源股份有限公司 关于2025年第一季度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司已于 2025 年 4 月 30 日披露了 2025 年第一季度报告，于 2025 年 5 月 28 日披露了《关于召开 2025 年一季度业绩说明会的公告》（公告编号：2025-040）。 2025 年 6 月 5 日（星期五）11：00-12:00，公司在上证路演中心网络互动 平台召开 2025 年第一季度业绩说明会，公司党委书记、董事长尤明杨先生，独 立董事秦海岩先生，副总经理兼董事会秘书（代行总经理职责）范晓波先生，副 总经理兼财务负责人宋璐璐女士出席了本次说明会，与投资者进行了深入的沟通 和交流，就投资者普遍关注的问题进行了解答。 二、本次会议投资者提出的主要问题及公司回复情况 问题一：未来是否会将智算作为第二主业？预计何时实现规模化收益？ 回复：尊敬的投资者，您好。近年来，国家深入实施"东数西算"工程，加 ...

司章程》及相关 附件的议案 (三) 关于议案表决的有关情况说明 根据上述本次股东大会审议的各项议案表决结果，上述议案均获得通过，且第 8、 三、 律师见证情况 证券代码：600821 证券简称：金开新能 公告编号：2025-043 金开新能源股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东大会召开的时间：2025 年 6 月 4 日 (二) 股东大会召开的地点：北京市西城区新兴东巷 10 号三层会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 份总数的比例（%） 37.3764 (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会采取现场投票与网络投票相结合的表决方式，均符合《公司法》 及《公司章程》的规定。本次股东大会由公司董事会召集，由公司董事长尤明杨 先生主持本次股东大会，符合《公司法》和《公司章程》的有关规定。 (五) 公司董事、监事和董事会秘书的出席情况 ...

证券代码：600821 证券简称：金开新能 公告编号：2025-043 金开新能源股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东大会召开的时间：2025 年 6 月 4 日 (二) 股东大会召开的地点：北京市西城区新兴东巷 10 号三层会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 667 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 746,505,594 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 37.3764 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会采取现场投票与网络投票相结合的表决方式，均符合《公司法》 及《公司章程》的规定。本次股东大会由公司董事会召集，由公司董事长尤明杨 ...